Alison Reid

2.2k total citations
20 papers, 1.1k citations indexed

About

Alison Reid is a scholar working on Pulmonary and Respiratory Medicine, Cancer Research and Radiology, Nuclear Medicine and Imaging. According to data from OpenAlex, Alison Reid has authored 20 papers receiving a total of 1.1k indexed citations (citations by other indexed papers that have themselves been cited), including 15 papers in Pulmonary and Respiratory Medicine, 7 papers in Cancer Research and 5 papers in Radiology, Nuclear Medicine and Imaging. Recurrent topics in Alison Reid's work include Prostate Cancer Treatment and Research (15 papers), Hormonal and reproductive studies (5 papers) and Radiopharmaceutical Chemistry and Applications (4 papers). Alison Reid is often cited by papers focused on Prostate Cancer Treatment and Research (15 papers), Hormonal and reproductive studies (5 papers) and Radiopharmaceutical Chemistry and Applications (4 papers). Alison Reid collaborates with scholars based in United Kingdom, United States and France. Alison Reid's co-authors include Johann S. de Bono, Timothy A. Yap, Debashis Sarker, Gerhardt Attard, David P. Dearnaley, Chris Parker, David Olmos, Daniel Brewer, Ioanna Ledaki and Joo Ern Ang and has published in prestigious journals such as Journal of Clinical Oncology, SHILAP Revista de lepidopterología and Cancer Research.

In The Last Decade

Alison Reid

20 papers receiving 1.1k citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
Alison Reid United Kingdom	13	746	412	400	306	143	20	1.1k
Carl Le United States	7	740 1.0×	584 1.4×	372 0.9×	249 0.8×	181 1.3×	10	1.2k
Stephanie Greene United States	9	563 0.8×	458 1.1×	507 1.3×	443 1.4×	74 0.5×	18	1.3k
David Lu United States	12	800 1.1×	361 0.9×	594 1.5×	549 1.8×	112 0.8×	27	1.2k
Holger H.H. Erb Germany	17	453 0.6×	626 1.5×	393 1.0×	366 1.2×	60 0.4×	58	1.2k
Suman Bhattacharya United States	12	538 0.7×	346 0.8×	370 0.9×	713 2.3×	160 1.1×	26	1.2k
Maria Thadani‐Mulero United States	7	521 0.7×	307 0.7×	255 0.6×	203 0.7×	148 1.0×	11	797
Hege Chen China	12	768 1.0×	825 2.0×	468 1.2×	172 0.6×	55 0.4×	12	1.4k
Andreas Josefsson Sweden	18	456 0.6×	340 0.8×	222 0.6×	257 0.8×	89 0.6×	38	935
Paula Kaplan‐Lefko United States	13	345 0.5×	620 1.5×	208 0.5×	557 1.8×	92 0.6×	26	1.3k
Michaela J. Higgins United States	18	246 0.3×	680 1.7×	413 1.0×	530 1.7×	94 0.7×	60	1.3k

Countries citing papers authored by Alison Reid

Since Specialization

Citations

This map shows the geographic impact of Alison Reid's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Alison Reid with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Alison Reid more than expected).

Fields of papers citing papers by Alison Reid

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Alison Reid. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Alison Reid. The network helps show where Alison Reid may publish in the future.

Co-authorship network of co-authors of Alison Reid

This figure shows the co-authorship network connecting the top 25 collaborators of Alison Reid. A scholar is included among the top collaborators of Alison Reid based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Alison Reid. Alison Reid is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

Reid, Alison, et al.. (2025). LBA6 Phase III trial of [177Lu]Lu-PSMA-617 combined with ADT + ARPI in patients with PSMA-positive metastatic hormone-sensitive prostate cancer (PSMAddition). Annals of Oncology. 36. S1627–S1628. 1 indexed citations

Reid, Alison, et al.. (2021). Regulatory Authorities and Continuing Education Around the World: Adapting to COVID-19. SHILAP Revista de lepidopterología. 10(1). 2014095–2014095. 1 indexed citations

Shapiro, Jeremy, Ray McDermott, Josep M. Piulats, et al.. (2019). Abstract 727: Comprehensive genomic profiling of >1000 plasma and tumor tissue samples from metastatic castration-resistant prostate cancer (mCRPC) patients gives insight into targeted treatment strategies. Cancer Research. 79(13_Supplement). 727–727. 1 indexed citations

Thiery-Vuillemin, Antoine, Mads Hvid Poulsen, É. Lagneau, et al.. (2019). Impact of Abiraterone Acetate plus Prednisone or Enzalutamide on Patient-reported Outcomes in Patients with Metastatic Castration-resistant Prostate Cancer: Final 12-mo Analysis from the Observational AQUARiUS Study. European Urology. 77(3). 380–387. 43 indexed citations

Rescigno, Pasquale, David Lorente, Diletta Bianchini, et al.. (2016). Prostate-specific Antigen Decline After 4 Weeks of Treatment with Abiraterone Acetate and Overall Survival in Patients with Metastatic Castration-resistant Prostate Cancer. European Urology. 70(5). 724–731. 52 indexed citations

Pezaro, Carmel, Deborah Mukherji, Nina Tunariu, et al.. (2013). Sarcopenia and change in body composition following maximal androgen suppression with abiraterone in men with castration-resistant prostate cancer. British Journal of Cancer. 109(2). 325–331. 36 indexed citations

Reid, Alison, Gerhardt Attard, Daniel Brewer, et al.. (2012). Novel, gross chromosomal alterations involving PTEN cooperate with allelic loss in prostate cancer. Modern Pathology. 25(6). 902–910. 35 indexed citations

Messiou, Christina, Gary Cook, Alison Reid, et al.. (2011). The CT flare response of metastatic bone disease in prostate cancer. Acta Radiologica. 52(5). 557–561. 42 indexed citations

Reid, Alison, Gerhardt Attard, Laurence Ambroisine, et al.. (2010). Molecular characterisation of ERG, ETV1 and PTEN gene loci identifies patients at low and high risk of death from prostate cancer. British Journal of Cancer. 102(4). 678–684. 201 indexed citations

10.

Attard, Gerhardt, Siân Rizzo, Ioanna Ledaki, et al.. (2009). A novel, spontaneously immortalized, human prostate cancer cell line, Bob, offers a unique model for pre‐clinical prostate cancer studies. The Prostate. 69(14). 1507–1520. 10 indexed citations

11.

Sarker, Debashis, Alison Reid, Timothy A. Yap, & Johann S. de Bono. (2009). Targeting the PI3K/AKT Pathway for the Treatment of Prostate Cancer. Clinical Cancer Research. 15(15). 4799–4805. 292 indexed citations

12.

Reid, Alison, Gerhardt Attard, Daniel C. Danila, et al.. (2009). A multicenter phase II study of abiraterone acetate (AA) in docetaxel pretreated castration-resistant prostate cancer (CRPC) patients (pts). Journal of Clinical Oncology. 27(15_suppl). 5047–5047. 16 indexed citations

13.

Olmos, David, Hendrik‐Tobias Arkenau, Joo Ern Ang, et al.. (2008). Circulating tumour cell (CTC) counts as intermediate end points in castration-resistant prostate cancer (CRPC): a single-centre experience. Annals of Oncology. 20(1). 27–33. 194 indexed citations

14.

Reid, Alison, et al.. (2008). CYP17 inhibition as a hormonal strategy for prostate cancer. Nature Clinical Practice Urology. 5(11). 610–620. 88 indexed citations

15.

Jhavar, Sameer, Alison Reid, Jeremy Clark, et al.. (2007). Detection of TMPRSS2-ERG Translocations in Human Prostate Cancer by Expression Profiling Using GeneChip Human Exon 1.0 ST Arrays. Journal of Molecular Diagnostics. 10(1). 50–57. 43 indexed citations

16.

Reid, Alison, James Spicer, Elisa Gallerani, et al.. (2007). An exploration of the ability of DCE-CT scans to evaluate blood flow in an open, pharmacokinetic (PK) and mass balance study of 14[C]-cediranib. 6. 3 indexed citations

17.

Reid, Alison, James Spicer, Elisa Gallerani, et al.. (2007). An open, pharmacokinetic (PK) and mass balance study of ¹⁴C-AZD2171, incorporating DCE-CT evaluations. Journal of Clinical Oncology. 25(18_suppl). 14140–14140. 3 indexed citations

18.

Yap, Timothy A., Gerhardt Attard, Alison Reid, et al.. (2007). 594: Abiraterone Acetate, an Oral Irreversible Inhibitor of CYP450C17, Administered to Castration Refractory Prostate Cancer Patients is Safe, Suppresses Androgen and Steroid Precursor Levels, and has a High Degree of Durable Antitumor Activity. The Journal of Urology. 177(4S). 199–199. 1 indexed citations

19.

Attard, Gerhardt, Timothy A. Yap, Alison Reid, et al.. (2007). Phase I study of continuous oral dosing of an irreversible CYP17 inhibitor, abiraterone (A), in castration refractory prostate cancer (CRPC) patients (p) incorporating the evaluation of androgens and steroid metabolites in plasma and tumor. Journal of Clinical Oncology. 25(18_suppl). 5063–5063. 13 indexed citations

20.

Goodall, H. B., Alison Reid, D.J.S. Findlay, et al.. (1994). Irregular Distortion of The Erythrocytes (Acanthocytes, Spur Cells) in Senile Dementia. Disease Markers. 12(1). 23–41. 20 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact